Gene

FH - hereditary leiomyomatosis and renal cell cancer

Turnaround time
Complete analysis & Targeted analysis: 3 weeks
Performing laboratory
Radboudumc
€ 674

FH - hereditary leiomyomatosis and renal cell cancer



€ 674

FH - hereditary leiomyomatosis and renal cell cancer

This test is available for the following conditions:

  • Conditions > Renal / Nephrological > Leiomymatosis + kidney cancer
  • Conditions > Oncogenetics > Leiomymatosis + kidney cancer

This product is also part of the following panels:

  • panel hereditary renalcancer (SDHA, SDHB, SDHC, SDHD, SDHAF2, VHL, PTEN, FLCN, MET, FH, BAP1)
  • WES comprehensive preconception carrier test ¹
  • WES hereditary cancer (100.0% *)
  • WES intellectual disability (100.0% *)
  • WES liver disorders (100.0% *)
  • WES Mendelian inherited disorders (100.0% *)
  • WES metabolic disorders (100.0% *)
  • WES mitochondrial disorders (100.0% *)
  • WES skin disorders¹ (100.0% *)

* % of the coding region of this gene has a coverage of >20x. (Without % information : This is a non-coding gene for which coverage statistics could not be determined)

Turnaround time
Complete analysis & Targeted analysis: 3 weeks

Method

  • Sequence analysis of all coding exons and flanking intron-exon boundaries
  • Deletion/duplication analysis (MLPA)

OMIM: 136850
Performing laboratory: Radboudumc
Authorized material(s): EDTA blood, FFPE, Isolated DNA




€ 674